Latest News

04/02/2017

Genoscience Pharma to present data at the AACR Annual meeting 2017- Washigton, D.C. (Abstract n°1/2)

Abstract: Background: Hepatocellular carcinoma (HCC) remains a major health problem, often diagnosed atlate stages with...

03/16/2017

Genoscience Pharma to present data at the 38th EORTC-PAMM Winter meeting_16th-18th March, Split, Croatia

Background: In spite of wide application of sorafenib for hepatocellular carcinoma (HCC) treatment, and systemic chemotherapy...

10/31/2016

Genoscience Pharma to present data on its promising candidate GNS561 at the Liver meeting 2016- AASLD

Abstract: Background: In spite of successful approval and wide application of sorafenib, the prognosis for patients with...

06/03/2016

Genoscience Pharma to present data on its most promising candidate GNS561 at the 2016 ASCO Annual Meeting

Abstract: In spite of successful approval and wide application of sorafenib, the prognosis for patients with advanced...

02/25/2016

Cancer stem cells: Genoscience Pharma welcomes Pharmacyclics former senior management team to its board of directors

Marseille, February 24, 2016 – Genoscience Pharma, a biopharmaceutical company dedicated to discovering and developing...

07/30/2015

Genoscience Pharma to present data on its most promising candidate GNS561 at the Liver meeting 2015- AASLD

Abstract: Background: In spite of successful approval and wide application of sorafenib, the prognosis for patients with...

09/19/2014

26th EORTC-NCI-AACR SYMPOSIUM

Abstract: Despite efforts to understanding and treat acute myeloid leukemia (AML), there remains a need to more comprehensive...

07/30/2014

Oral treatment for Hepatitis C

BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C BioLineRx (NASDAQ: BLRX; TASE:...

View all